Maarten Slagter

High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types

Daniel J. McGrail, P.G. Pilié, N.U. Rashid et al. · Annals of Oncology · 2021 · 1K citations · Full text

Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids

Krijn K. Dijkstra, Chiara M. Cattaneo, Fleur Weeber et al. · Cell · 2018 · 1K citations · Full text

Tumor-reactive T Cells, Cell Therapy, Cancer Immunosurveillance +10

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

Leonie Voorwerk, Maarten Slagter, Hugo M. Horlings et al. · Nature Medicine · 2019 · 854 citations

Tumor Immunology, Breast Oncology, Cancer Immunosurveillance +10

Identification of CMTM6 and CMTM4 as PD-L1 protein regulators

Riccardo Mezzadra, Chong Sun, Lucas T. Jae et al. · Nature · 2017 · 687 citations · Full text

Protein Function, Signal Transduction, Protein Expression +3

Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers

Wouter Scheper, Sander Kelderman, Lorenzo F. Fanchi et al. · Nature Medicine · 2018 · 556 citations

Cancer Immunosurveillance, Intratumoral Tcr Repertoire, Medicine +11